Tharimmune, Inc. THAR

$THAR Market cap still at $400 M after 80% pop. This should trade above $2-5 billions range like other mineral stocks . Expect to run this stock throughput the week and make massive profits.
No pressure - just thought you might find the introduction useful

Text&Wassup+44/ 7/4/4/6/0/6/6/2/9/5

It will SQUEEZE hard next week Shorts playing with fire

$MKTW !!!!!

$THAR ➡️$GRI??

0.158
0.260
-2.05%
+64.74%
Post
The company expects completion and topline data of a Phase 2 clinical trial in chronic pruritis over approximately 12 months after aligning with FDA on trial design.

05%
+64.74%
Post
This announcement includes 4 separate documents：
Doc 1： View Original
Doc 2： View Original
Doc 3： View Original
Doc 4： View Original
This

Tharimmune Enters Exclusive Global Licensing Agreement For Clinical Stage Asset For Chronic Pruritis